trending Market Intelligence /marketintelligence/en/news-insights/trending/31cnLgSgPwH_V3nKnMP6Lw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

1Life Healthcare plans Nasdaq IPO

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

1Life Healthcare plans Nasdaq IPO

1Life Healthcare Inc. is planning an IPO to list its shares on the Nasdaq Global Select Market under the symbol ONEM.

The San Francisco-based company offers technology solutions to its members that enable access to physicians through video and mobile-based applications.

The company plans to use proceeds for general corporate purposes, including working capital, research and development, business development, sales and marketing activities as well as capital expenditures.

Tom Lee is the founder and CEO of 1Life Healthcare, and Sharon Knight is the company's president.

Asset management company The Carlyle Group LLC and Benchmark Capital Partners V LP own a 26.8% and 13% stake, respectively, in 1Life Healthcare.

J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC are the joint book-running managers for the IPO.